Name | 1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-, hydrochloride |
---|---|
Synonyms |
Imiquimod (hydrochloride)
1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-, monohydrochloride Imiquimod hydrochloride |
Description | Imiquimod hydrochloride is an immune response modifier that acts as a toll-like receptor 7agonist. |
---|---|
Related Catalog | |
Target |
Toll-like receptor 7 |
In Vivo | In animal models, imiquimod stimulates the innate immune response by increasing NK cell activity, activating macrophages to secretecytokines and nitric oxide, and inducing proliferation and differentiation of B lymphocytes. Imiquimod stimulates the innate immune response through induction, synthesis, and release of cytokines, including interferon-a (IFN-α), interleukin (IL)-6, and tumour necrosis factor (TNF)-α[1]. |
References |
[1]. Bilu D, et al. Imiquimod: modes of action. Br J Dermatol. 2003 Nov;149 Suppl 66:5-8. |
Molecular Formula | C14H17ClN4 |
---|---|
Molecular Weight | 276.76500 |
Exact Mass | 276.11400 |
PSA | 56.73000 |
LogP | 4.20590 |